Turkish Offensive in Syria, U.S.-China Trade Talks Resume, CRISPR Patient Update The U.S. has taken custody of high-value ISIS fighters as Turkey begins its offensive on the allied Kurdish forces that detained them. U.S. and Chinese negotiators return to the bargaining table in Washington. And we follow one of the first patients to be treated for a genetic disease using the gene-editing technique known as CRISPR.
NPR logo

Turkish Offensive in Syria, U.S.-China Trade Talks Resume, CRISPR Patient Update

  • Download
  • <iframe src="https://www.npr.org/player/embed/768830627/768842658" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Turkish Offensive in Syria, U.S.-China Trade Talks Resume, CRISPR Patient Update

Turkish Offensive in Syria, U.S.-China Trade Talks Resume, CRISPR Patient Update

Turkish Offensive in Syria, U.S.-China Trade Talks Resume, CRISPR Patient Update

  • Download
  • <iframe src="https://www.npr.org/player/embed/768830627/768842658" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The U.S. has taken custody of high-value ISIS fighters as Turkey begins its offensive on the allied Kurdish forces that detained them. U.S. and Chinese negotiators return to the bargaining table in Washington. And we follow one of the first patients to be treated for a genetic disease using the gene-editing technique known as CRISPR.